|
Delayed
Australian S.E.
02:10:20 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.4500 AUD | -1.10% |
|
-2.17% | -54.08% |
| 09-01 | Cyclopharm Limited, H1 2026 Earnings Call, Sep 02, 2026 | |
| 08-24 | Cyclopharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Cyclopharm Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 153.1 | 108.9 | 181.1 | 176.2 | 108.9 | 56.58 | - | - |
| Change | - | -28.9% | 66.37% | -2.75% | -38.17% | -48.05% | - | - |
| Enterprise Value (EV) | 128.4 | 108.9 | 181.1 | 176.2 | 108.9 | 56.58 | 56.58 | 56.58 |
| Change | - | -15.2% | 66.37% | -2.75% | -38.17% | -48.05% | 0% | 0% |
| P/E | -29.3x | -16.2x | -39.5x | -12x | -5.94x | -3.15x | -4.94x | -11.1x |
| PBR | 3.57x | - | 5.84x | 4.06x | 3.85x | 2.36x | 2.44x | 2.09x |
| PEG | - | -0.8x | 1.2x | -0x | -0.2x | 0.3x | 0.1x | 0.2x |
| Capitalization / Revenue | 8.65x | 4.69x | 6.88x | 6.39x | 3.37x | 1.52x | 1.2x | 1x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.52x | 1.2x | 1x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -3.85x | -5.55x | -14.5x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.43x | -4.72x | -9.93x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -3.82x | -5.01x | -11.3x |
| FCF Yield | -1.61% | - | -4.09% | -7.69% | -14.1% | -26.2% | -20% | -8.84% |
| Dividend per Share 2 | 0.00724 | - | 0.00328 | - | - | - | - | - |
| Rate of return | 0.61% | - | 0.25% | - | - | - | - | - |
| EPS 2 | -0.0407 | -0.0491 | -0.0332 | -0.0816 | -0.1105 | -0.0989 | -0.0631 | -0.028 |
| Distribution rate | -17.8% | - | -9.88% | - | - | - | - | - |
| Net sales 1 | 17.7 | 23.22 | 26.34 | 27.57 | 32.33 | 37.2 | 47.2 | 56.7 |
| EBITDA 1 | -3.499 | -4.832 | -7.611 | -11.95 | -15.4 | -14.7 | -10.2 | -3.9 |
| EBIT 1 | -4.258 | -5.764 | -8.55 | -13.42 | -17.17 | -16.5 | -12 | -5.7 |
| Net income 1 | -5.04 | -6.612 | -4.701 | -13.2 | -17.22 | -17.4 | -12.4 | -6.1 |
| Net Debt | -24.74 | - | - | - | - | - | - | - |
| Reference price 2 | 1.1903 | 0.7952 | 1.3122 | 0.9809 | 0.6567 | 0.3115 | 0.3115 | 0.3115 |
| Nbr of stocks (in thousands) | 93,375 | 93,054 | 94,096 | 111,137 | 111,137 | 125,734 | - | - |
| Announcement Date | 2/23/22 | 2/20/23 | 2/27/24 | 2/24/25 | 2/25/26 | - | - | - |
1AUD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.2x | - | - | - | 39.78M | |
| 33.55x | 5.86x | 22.46x | 0.27% | 250B | |
| 37.53x | 6.7x | 21.23x | 0.64% | 156B | |
| 44.07x | 11.66x | 25.74x | -.--% | 144B | |
| 16.51x | 3.39x | 11.05x | -.--% | 63.26B | |
| 34.11x | 6.82x | 21.58x | -.--% | 49.75B | |
| 33.56x | 6.64x | 22.54x | 0.6% | 48.58B | |
| 18.65x | 2.28x | 11.55x | 2.7% | 47.99B | |
| 43.7x | 10.61x | 23.39x | -.--% | 46.22B | |
| 76.92x | 7.32x | 22.3x | -.--% | 43.17B | |
| Average | 33.54x | 6.81x | 20.20x | 0.47% | 84.8B | |
| Weighted average by Cap. | 36.74x | 7.04x | 21.32x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CYC Stock
- Valuation Cyclopharm Limited
Select your edition
All financial news and data tailored to specific country editions
